Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05339659 · ClinicalTrials.gov registry record · NA
Randomized Pilot Study of a mHealth App for Ambivalent Smokers Living With HIV
A NA study of Smoking Cessation and Smoking, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT05339659: Completed NA study of Smoking Cessation and Smoking, sponsored by Kaiser Permanente.
NCT05339659 is a NA study of Smoking Cessation and Smoking that has completed, run by Kaiser Permanente. The registered enrollment target is 22 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05339659, a NA study of Smoking Cessation and Smoking, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will assess the acceptability and feasibility a novel mHealth app designed for smokers who are ambivalent about quitting and have been diagnosed with HIV.
Primary Outcome
Number of unique app user-sessions
Conditions Studied
Interventions
- DEVICE mHealth Intervention
Study Locations (1)
Washington
- Kaiser Permanente WA Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-06-02 |
| Est. Completion | 2023-05-20 |
| Phase | NA |
What the finished NCT05339659 record still lists
NCT05339659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which mHealth Intervention is the first listed.
NCT05339659 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05339659 about?
NCT05339659 is a clinical study titled "Randomized Pilot Study of a mHealth App for Ambivalent Smokers Living With HIV". This pilot study will assess the acceptability and feasibility a novel mHealth app designed for smokers who are ambivalent about quitting and have been diagnosed with HIV.
What is the current status of trial NCT05339659?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2022-06-02. Estimated completion is 2023-05-20.
What conditions does trial NCT05339659 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking.
What interventions are being tested in trial NCT05339659?
The interventions under investigation include: mHealth Intervention (DEVICE).
Who is sponsoring clinical trial NCT05339659?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05339659 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05339659's enrollment target sits among peer trials
22 172nd of 188 higher than 17 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI